Join
Live feed
·
INSIDERFilingvia Quantisnow
UroGen Pharma Ltd. logo

Chief Medical Officer Schoenberg Mark converted options into 1,667 units of Ordinary Shares and sold $16,645 worth of Ordinary Shares (871 units at $19.11), increasing direct ownership by 0.54% to 149,025 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track URGN (UroGen Pharma Ltd.) and more on Quantisnow.